巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Reneo Pharmaceuticals

    RPHM
    2.600
    0.010
    0.38%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Reneo Pharmaceuticals - 延遲價格・最後更新於 01/07 12:14
    最高位
    2.780
    最低位
    2.600
    開市價
    --
    前收市價
    2.610
    成交量(千)
    1.43
    成交額(百萬)
    0.03
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    63.59
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    11.400 - 1.920
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Reneo Pharmaceuticals
    證券代碼
    RPHM.US
    所屬板塊
    Biotechnology
    公司業務
    Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
    發行量
    24458550
    公司總部
    18575 Jamboree Road, Suite 275-S
    公司網址
    https://www.reneopharma.com
    公司電話
    +1 619 733-3852
    暫無內容

    關於

    Reneo Pharmaceuticals(RPHM.US)所屬的行業板塊為Biotechnology。
    Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
    詳細公司背景可參考: https://www.reneopharma.com